Libtayo is the first investigational medicine to show a clinical benefit in advanced basal cell carcinoma following treatment with a…
The first Rhenium-SCT® treatment was accomplished by the interregional professional association for nuclear medicine in Hanau (PRESS RELEASE) HANAU, Germany,…
New recognition of OncoBeta’s success in developing and providing an innovative therapy for non-melanoma skin cancer patients. (PRESS RELEASE) Pasadena,…
The interregional professional association for nuclear medicine in Hanau is the first treatment center in Germany offering Rhenium-SCT® for the…
https://www.youtube.com/watch?v=RylXHwSa_kc University of Pretoria Prof. Mike Sathekge is First in South Africa to Treat Non-Melanocytic Skin Cancer Patients with Rhenium-SCT®…